mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.05 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.05 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.05 |
mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.05 |
mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.06 |
mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
0.12 |
0.06 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.06 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.06 |
mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.07 |